Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Histrelin acetate (substance) |
Is a |
False |
Histrelin |
Inferred relationship |
Some |
|
Product containing histrelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Histrelin |
Inferred relationship |
Some |
1 |
Histrelin 200mcg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histrelin |
Inferred relationship |
Some |
|
Histrelin 500mcg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histrelin |
Inferred relationship |
Some |
|
Histrelin 1000mcg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histrelin |
Inferred relationship |
Some |
|
histrelin 120 µg/0,6 ml (200 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histrelin |
Inferred relationship |
Some |
|
histrelin 600 µg/0,6 ml (1000 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histrelin |
Inferred relationship |
Some |
|
histrelin 300 µg/0,6 ml (500 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histrelin |
Inferred relationship |
Some |
|
histrelin 50 mg implantat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histrelin |
Inferred relationship |
Some |
|
Histrelin acetate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Histrelin |
Inferred relationship |
Some |
|
Product containing only histrelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Histrelin |
Inferred relationship |
Some |
1 |